A possible mechanism explaining this microglial metabolic reprogramming has been described in a mouse model of AD, where Aβ directly triggers microglial inflammation together with a metabolic reprogramming from oxidative phosphorylation to glycolysis, in mTOR-HIF-1α pathway-dependent manner (78). The gene discussed is MTOR; the disease is Alzheimer disease.